Ipamorelin

Manufacture Bodybuilding Peptide Ipamorelin for weight loss

Ipamorelin

 

CAS:170851-70-4
Model NO.:CZG-P10
Name:Ipamorelin
Specification:5mg/Vial, 10vial/Box
CAS Number:170851-70-4
MOQ:1box
Mf:C38h49n9o5
Purity:99%
MW:711.86
Appearance:White Freeze-Dried Powder
Sotre at:Cool Dry Place
Type:Pharmaceutical Intermediates
Export Markets:Global

 

Ipamorelin, being a newly synthetic supplement on the market, is still being studied and under research for its effects on the body and how it works so well to produce muscle gain and weight loss. So far the findings for its effect on muscle growth are very positive. When Ipamorelin peptides release growth hormones, the cells go straight to the muscle to support its larger development and seems to steer clear of any possible bone or cartilage distortions. Researchers have also found that Ipamoelin does not decrease your body’s natural production of growth hormone. So your own individual growth hormone works as well, maximizing your muscle growth benefits.

Summary of iPamorelin benefits:

 

According to scientific study that has been built around animal test subjects, it has been determined that Ipamorelin's primary functionality is associate with the stimulation of the pituitary gland.  This is the pea-sized gland that is located in the bottom of the hypothalamus at the base of the brain and is responsible for the regulation and control of a host of functions that relate to the endocrine system. 

Some of these functions include:

 Growth
Functionality of the thyroid gland
Regulation of temperature
Regulation of blood pressure
Functionality of sex organs
Pain relief

 

Dosage


The average dosing for Ipamorelin is 200-300mcg two to three times daily.

Twelve week cycles are quite normal and PCT would be very minimal - mini-pct is fine.

If prolactin issues ever arise, there are products that help reduce prolactin and estrogen-like symptoms. These include aromatase inhibitors (Aromasin, Arimidex, Letrozole), and anti-prolactin aids like Dostinex (Cabergoline).